The US CDC expects that a COVID-19 vaccine may become available by the end of 2020. Officials have updated on the status of vaccine plans and have mentioned some important considerations...
In a study published in Science Direct, Health -Related Quality of Life (HRQoL) was evaluated in survivors of severe COVID-19 infection at 3 months. A second study (currently a preprint) compared 58 COVID-19 patients, post-hospital discharge, with 30 matched controls (with similar comorbidities) . Similar results were discovered in another preprint study looking at long-term neurologic outcomes, also referred as the “Long-Haul COVID” 3 moths after COVID-19
English
Japanese
